Author: Ravi Shankar

• Multiple pre-specified subgroup analyses favored camupepimut (ELI-002 7P), including patients with and without detectable baseline ctDNA.
• Encouraging disease-free survival outcomes were observed in both ctDNA-negative (HR 0.51) and ctDNA-positive (HR 0.57) patients.
• Baseline prognostic imbalances provide important context for the intent-to-treat results, including a 53% lower risk of recurrence or death with camupepimut (multivariable adjusted HR 0.47; p=0.0086).
• Integrated clinical and translational findings provide clear direction for refining patient stratification, optimizing dosing and advancing Phase 3 development.

BOSTON, Oct. 23, 2026 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced results from the randomized Phase 2 AMPLIFY-7P study of camupepimut (ELI-002 7P), presented in a late-breaking Proffered Paper oral session at the European Society for Medical Oncology (“ESMO”) Congress 2026 in Madrid, Spain, and simultaneously published in Nature Medicine: “Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial”.

Across multiple pre-specified analyses, camupepimut demonstrated consistent and favorable treatment-effect trends in patients with and without detectable baseline ctDNA and in patients without prior radiation. While the study did not meet its pre-specified primary disease-free survival (“DFS”) endpoint in the intent-to-treat (“ITT”) population (HR 0.85), the results should be considered in the context of a baseline imbalance in ctDNA positivity, a strong predictor of recurrence, which was more prevalent in the camupepimut arm (20.8% vs. 12.5%). Translational analyses also demonstrated broad, persistent mutant KRAS-specific T-cell responses associated with longer DFS. Together, these findings inform a refined Phase 3 development strategy.

“The AMPLIFY-7P results provide important new insights into camupepimut’s clinical activity and reinforce our confidence in its potential for patients with pancreatic cancer,” said Robert Connelly, President and Chief Executive Officer of Elicio. “We are encouraged by the consistent treatment-effect trends across pre-specified patient groups, including patients with and without detectable baseline ctDNA, and by the strong mKRAS-specific immune responses associated with clinical outcomes. These insights give us clear direction for our potential Phase 3 strategy.”

Pre-Specified Analyses Show Consistent Treatment-Effect Direction Across Baseline ctDNA Subgroups

• In the 93 patients with baseline ctDNA-negative status, median DFS was not reached in the camupepimut arm vs. 21.2 months in the observation arm (HR 0.51; nominal p=0.0280). Recurrence or death was observed in 27.4% (17/62) of camupepimut-treated patients vs. 48.4% (15/31) of patients in observation.
• A consistent treatment effect was also observed in the smaller, higher-risk baseline ctDNA-positive subgroup (n=26). Median DFS was 4.3 months with camupepimut vs. 1.9 months with observation (HR 0.57; nominal p=0.0489).
• Prior radiation predicted lower baseline lymphocyte counts and reduced camupepimut-induced mKRAS T cell responses. In pre-specified analysis, patients who had not received prior radiation (n=106) had median DFS of 23.8 months with camupepimut vs. 10.4 months with observation (HR 0.59; nominal p=0.0221).

Pre-specified Subgroup	Arm	N	Median DFS	HR, p-value
ctDNA negative	Camupepimut	62	Not Reached	HR 0.51
	Observation	31	21.2 Months	P=0.0280
ctDNA positive	Camupepimut	20	4.3 Months	HR 0.57
	Observation	6	1.9 Months	P=0.0489
No Prior Radiation	Camupepimut	73	23.8 Months	HR 0.59
	Observation	33	10.4 Months	P=0.0221

Baseline Prognostic Imbalance Provides Important Context for ITT Results

• Baseline ctDNA status emerged as a particularly strong prognostic marker. In a pooled analysis across treatment groups, median DFS was 4.2 months for ctDNA-positive patients versus 24.0 months for ctDNA-negative patients (HR 6.56; nominal p<0.000001). Patients with baseline ctDNA positivity were more prevalent in the camupepimut arm (20.8%; 20/96) than in the observation arm (12.5%; 6/48).
• A multivariable model adjusting for baseline factors estimated an association between camupepimut treatment and lower recurrence risk (adjusted HR 0.47; p=0.0086), while elevated CA19-9 (adjusted HR 3.16; p<0.0001) and positive baseline ctDNA (adjusted HR 5.99; p<0.0001) were associated with higher risk.

Early DFS Separation and Immune Findings Support Further Evaluation

• Six-month DFS was 75.7% with camupepimut vs. 61.7% with observation, a 14.0 percentage-point difference immediately following the treatment period supports evaluating treatment duration in future studies.
• Camupepimut induced mutant KRAS-specific T-cell responses in 99% of evaluable treated patients (median 44.3-fold increase from baseline. Among patients evaluated for T-cell subsets, 85% generated both CD4 and CD8 responses. Responses persisted at least 46 weeks from baseline in 95.5% of evaluable treated patients; 13 of 15 patients in a selected subset showed responses to additional tumor targets.
• In an exploratory analysis, stronger camupepimut-induced mutant KRAS-specific T-cell responses were associated with significantly longer DFS. Median DFS was not reached among patients with immune responses above a previously identified threshold (82%, 74/90) vs. 6.08 months among those below the threshold (HR 0.22; nominal p<0.0001).

Generally Well-Tolerated Safety Profile

• Camupepimut was generally well tolerated, with no new safety signals observed. Grade 3 or higher adverse events occurred in 10.4% of patients receiving camupepimut vs. 14.6% under observation; serious adverse events occurred in 6.3% and 8.3%, respectively. No adverse events led to withdrawal of study medication.

“The Phase 2 translational findings build on and reinforce our Phase 1 observations, demonstrating that camupepimut generates broad and persistent mutant KRAS-specific T-cell responses, with stronger immune responses associated with longer DFS,” said Christopher Haqq, M.D., Ph.D., Executive Vice President, Head of Research and Development and Chief Medical Officer of Elicio. “These observations across both baseline ctDNA subgroups and camupepimut’s favorable safety and tolerability profile provide a strong scientific and clinical rationale for a refined Phase 3 design incorporating optimized patient stratification, extended treatment duration and potential combination approaches.”

Implications for Further Development

Elicio plans to discuss the totality of AMPLIFY-7P findings with the U.S. Food and Drug Administration to inform a potential Phase 3 study in adjuvant pancreatic cancer. Areas for consideration include baseline ctDNA and other prognostic factors in stratification and patient selection, treatment duration, and combination strategies intended to deepen or sustain mutant KRAS-specific immune activity. Any future study design remains subject to regulatory discussion and further development planning.

About the AMPLIFY-7P Phase 2 Study

AMPLIFY-7P Phase 2 is a randomized study evaluating camupepimut versus observation in patients with mutant KRAS-driven pancreatic ductal adenocarcinoma following completion of standard locoregional therapy. The study enrolled 144 patients across 24 U.S. clinical sites.

About ELI-002

Elicio’s lead product candidate, ELI-002, is a structurally novel investigational Amphiphile (“AMP”) cancer immunotherapy that targets cancers driven by mutations in the KRAS gene, a prevalent driver of many human cancers. ELI-002 is comprised of AMP-modified mutant KRAS peptide antigens and ELI-004, an AMP-modified CpG oligodeoxynucleotide adjuvant, and is available as an off-the-shelf subcutaneous administration.

Camupepimut (ELI-002 7P), the seven-peptide formulation, was evaluated in the randomized Phase 2 AMPLIFY-7P trial in patients with mKRAS-driven pancreatic cancer. The ELI-002 7P formulation is designed to provide immune response coverage against seven of the most common KRAS mutations present across multiple solid tumors.

About Elicio Therapeutics

Elicio Therapeutics, Inc. (Nasdaq: ELTX) is a clinical-stage biotechnology company advancing next-generation immunotherapies for the treatment of KRAS-driven cancers, including mKRAS-positive pancreatic and colorectal cancers. Elicio intends to build on recent clinical findings in the personalized cancer immunotherapy space to develop effective, off-the-shelf immunotherapies.

Elicio’s AMP technology aims to enhance the education, activation and amplification of cancer-specific T cells relative to conventional immunotherapy strategies, with the goal of promoting durable cancer immunosurveillance in patients. Elicio’s ELI-002 7P lead program is an off-the-shelf immunotherapy candidate targeting the most common KRAS mutations, which drive approximately 25% of all solid tumors.

Off-the-shelf immunotherapy approaches have the potential benefits of low cost, rapid, commercial-scale manufacturing and rapid availability of drug to patients, especially in neoadjuvant settings and for prophylaxis in high-risk patients, contrary to personalized immunotherapy approaches.

Elicio’s pipeline includes additional off-the-shelf therapeutic cancer immunotherapy candidates, including ELI-007 and ELI-008, which target BRAF-driven cancers and p53 hotspot mutations, respectively.

For more information, please visit www.elicio.com.

Elicio Cautionary Note on Forward-Looking Statements

Certain statements contained in this communication regarding matters that are not historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, known as the PSLRA.

These include statements regarding the timing and content of Elicio’s presentation at ESMO Congress 2026; the clinical activity, therapeutic potential and potential benefits of camupepimut (ELI-002 7P); the interpretation and potential implications of results and analyses from the AMPLIFY-7P study; the potential for new pre-specified analyses to further characterize the clinical activity of camupepimut (ELI-002 7P); the potential for such analyses and the totality of AMPLIFY-7P findings to inform or support a refined Phase 3 development strategy; the potential benefits and effectiveness of off-the-shelf immunotherapy approaches; and other statements regarding management’s intentions, plans, beliefs, expectations or forecasts for the future and, therefore, you are cautioned not to place undue reliance on them.

No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. Elicio undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except to the extent required by law.

Elicio uses words such as “anticipates,” “believes,” “plans,” “expects,” “projects,” “future,” “intends,” “may,” “will,” “should,” “could,” “estimates,” “predicts,” “potential,” “continue,” “guidance,” and similar expressions to identify forward-looking statements intended to be covered by the safe-harbor provisions of the PSLRA.

Such forward-looking statements are based on Elicio’s expectations and involve risks and uncertainties; consequently, actual results may differ materially from those expressed or implied in the statements due to a number of factors, including, but not limited to, Elicio’s plans to develop and commercialize its product candidates, including camupepimut; the timing of the availability and presentation of data from Elicio’s clinical trials; Elicio’s plans to research, develop and commercialize its current and future product candidates; the design and timing of future clinical trials; and Elicio’s estimates regarding future revenue, expenses, capital requirements and need for additional financing.

New factors emerge from time to time, and it is not possible for Elicio to predict all such factors, nor can Elicio assess the impact of each such factor on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

These risks are more fully discussed under the heading “Risk Factors” in Elicio’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 12, 2026, as amended on April 29, 2026, Elicio’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed with the SEC on May 11, 2026, and Elicio’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, filed with the SEC on August 13, 2026 , as updated by subsequent reports and other documents filed from time to time with the SEC.

Forward-looking statements included in this release are based on information available to Elicio as of the date of this release. Elicio does not undertake any obligation to update such forward-looking statements to reflect events or circumstances after the date of this release, except to the extent required by law.

Elicio Investor Relations Contact

Brian Ritchie
LifeSci Advisors
(212) 915-2578
britchie@lifesciadvisors.com

Proposed acquisition would add 17 saltwater disposal facilities and approximately 11.5 million barrels per month of permitted disposal capacity, supporting Vivakor’s RPC strategy

Dallas, TX, Oct. 23, 2026 (GLOBE NEWSWIRE) — Vivakor, Inc. (Nasdaq: VIVK) (“Vivakor” or the “Company”), an integrated provider of energy transportation, storage, reuse and remediation services, today announced completion of its due diligence review of Direct Midstream, LLC, advancing the proposed $40 million acquisition toward a definitive purchase agreement.

The milestone moves Vivakor closer to a potential expansion of its Permian Basin infrastructure while advancing its Remediation Processing Center (“RPC”) strategy. Direct Midstream’s produced water management, disposal, oil reclamation and oilfield waste services would complement Vivakor’s transportation and terminaling businesses and its strategy for recovering reusable hydrocarbons from oilfield waste streams, broadening the services available across its energy infrastructure platform. The parties are now working toward finalizing the definitive agreement.

Direct Midstream’s platform includes seventeen saltwater disposal facilities and nine fresh water and brine stations, with approximately 11.5 million barrels per month of permitted disposal capacity. Its infrastructure serves oil and gas operators across the Permian Basin and would expand Vivakor’s ability to participate in multiple stages of the energy services value chain.

“Direct Midstream represents a substantial opportunity to expand the scale and reach of Vivakor’s infrastructure platform,” said James Ballengee, Chairman, President and Chief Executive Officer of Vivakor. “With due diligence complete, our focus is on finalizing a definitive agreement. Direct’s water management, disposal and oil reclamation capabilities would complement our transportation and terminaling operations while supporting our RPC strategy, positioning Vivakor to serve a broader range of customer needs across the Permian Basin.”

As previously announced, the LOI contemplates a $40 million gross purchase price and a $10 million capital investment by Vivakor into Direct Midstream at closing, with that investment reducing the consideration payable to the seller dollar-for-dollar. Final transaction terms will be set forth in the definitive agreement, if executed.

Execution of a definitive agreement and completion of the proposed acquisition remain subject to agreement on final terms, funding of the contemplated capital investment and other applicable conditions. There can be no assurance that a definitive agreement will be signed or that the acquisition will close.

About Direct Midstream

Direct Midstream is a provider of midstream energy and fluid management services serving oil and gas operators throughout the Permian Basin. The company’s services include saltwater disposal, produced water management, oil recovery and reclamation, slop oil processing and related oilfield waste services. Direct Midstream utilizes Class II UIC wells, automation and advanced monitoring systems to support safe, efficient and environmentally responsible operations.

About Vivakor, Inc.

Vivakor, Inc. is an integrated provider of sustainable energy transportation, storage, reuse, and remediation services. Its corporate mission is to develop, acquire, accumulate, and operate assets, properties, and technologies in the energy sector. Vivakor’s integrated facilities assets provide crude oil, storage, transportation, reuse, and remediation services under long-term contracts. Once operational, Vivakor’s interest in oilfield waste remediation facilities will facilitate the recovery, reuse, and disposal of petroleum byproducts and oilfield waste products.

Cautionary Statement Regarding Forward-Looking Statements

This news release may contain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements. Forward-looking statements may be identified but not limited by the use of the words “anticipates,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “estimates,” “potential,” or “continue” and variations or similar expressions. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including, but not limited to, the expected transaction and ownership structure, the valuation of the transaction, the likelihood and ability of the parties to successfully and timely consummate planned acquisitions, the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect Vivakor or the expected benefits of the such transaction, our ability to maintain the listing of our securities on The Nasdaq Capital Market, the parties failure to realize the anticipated benefits of pending transactions, disruption and volatility in the global currency, capital, and credit markets, changes in federal, local and foreign governmental regulation, changes in tax laws and liabilities, tariffs, legal, regulatory, political and economic risks, our ability to successfully develop products, rapid change in our markets, changes in demand for our future products, and general economic conditions.

These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor’s filings with the U.S. Securities and Exchange Commission, which factors may be incorporated herein by reference. Actual results, performance or achievements may differ materially, and potentially adversely, from any projections and forward-looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as projected financial information and other information are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond our control. All information set forth herein speaks only as of the date hereof in the case of information about Vivakor or the date of such information in the case of information from persons other than Vivakor, and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this communication. Forecasts and estimates regarding the industries and markets are based on sources we believe to be reliable; however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.

Investor Contact:
P:469-480-7175
info@vivakor.com

LIMASSOL, Cyprus, Oct. 23, 2026 (GLOBE NEWSWIRE) — AI OKTO CORP. (NASDAQ: AIOK) (“AI OKTO”, or the “Company”), an international ship-owning company providing energy transportation services globally, announced today that it has entered into an agreement with a wholly owned subsidiary of Robin Energy Ltd. (“Robin”), a Nasdaq-listed company controlled by our Chairman and Chief Executive Officer, for the sale of the Dream Arrax, a 2015-built 5,000 cbm LPG Carrier vessel for a sale price of $18 million.

The terms of the transaction were approved by the Boards of AI OKTO and Robin, following the negotiation and recommendation by special committees of the independent and disinterested directors of the Boards of AI OKTO and Robin.

The vessel is expected to be delivered to its new owner during the fourth quarter of 2026 and is subject to the satisfaction of certain customary closing conditions.

About AI OKTO CORP.

AI OKTO CORP. is an international ship-owning company providing energy transportation services globally. Following the above mentioned transaction, the Company’s fleet will consist of one 5,000 cbm LPG Carrier that carries petrochemical gases worldwide.

AI OKTO is incorporated under the laws of the Republic of the Marshall Islands. The Company’s common shares trade on the Nasdaq Capital Market under the symbol “AIOK”.

For more information, please visit the Company’s website at www.aiokto.com. Information on our website does not constitute a part of this press release.

Cautionary Statement Regarding Forward-Looking Statements

Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts, including statements related to the anticipated completion of the vessel sale and the timing of delivery of the vessel.

The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words “believe,” “anticipate,” “intends,” “estimate,” “forecast,” “project,” “plan,” “potential,” “may,” “should,” “expect” “pending” and similar expressions identify forward-looking statements. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, our management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs or projections. Please see the Company’s filings with the Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties. The information set forth herein speaks only as of the date hereof, and the Company disclaims any intention or obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or other developments occurring after the date of this communication.

CONTACT DETAILS

For further information please contact:

Investor Relations
AI OKTO CORP.
Email: ir@aiokto.com

LIMASSOL, Cyprus, Oct. 23, 2026 (GLOBE NEWSWIRE) — Robin Energy Ltd. (NASDAQ: RBNE) (“Robin Energy” or the “Company”), an international ship-owning company providing energy transportation services globally, announced today that it has entered into an agreement, through a wholly owned subsidiary, to acquire a 2015-built 5,000 cbm LPG Carrier vessel from AI OKTO CORP. (“AI OKTO”), a Nasdaq-listed entity controlled by our Chairman and Chief Executive Officer, for a purchase price of $18 million.

The terms of the transaction were approved by the Boards of Robin Energy and AI OKTO, following the negotiation and recommendation by special committees of the independent and disinterested directors of the Boards of Robin Energy and AI OKTO.

The acquisition is expected to be concluded by taking delivery of the vessel during the fourth quarter of 2026 and is subject to the satisfaction of certain customary closing conditions. The Company expects to fund the acquisition with cash on hand.

About Robin Energy Ltd.

Robin Energy is an international ship-owning company providing energy transportation services globally. Upon completion of the above-mentioned transaction, the Company’s fleet will comprise three LPG Carriers that carry petrochemical gases worldwide.

For more information, please visit the Company’s website at www.robinenergy.com. Information on our website does not constitute a part of this press release.

Cautionary Statement Regarding Forward-Looking Statements

Matters discussed in this press release may constitute forward-looking statements. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts, including those related to the completion, timing and benefits to the Company and shareholders of the vessel acquisition. We are including this cautionary statement in connection with this safe harbor legislation. The words “believe”, “anticipate”, “intend”, “estimate”, “forecast”, “project”, “plan”, “potential”, “will”, “may”, “should”, “expect”, “pending” and similar expressions identify forward-looking statements.

Forward-looking statements are subject to risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future and/or are beyond our control or precise estimate. Such risks, uncertainties and other factors include, but are not limited to, uncertainties related to the Company’s and its counterparty’s ability to consummate the transaction discussed herein, as well as those factors discussed under “Risk Factors” in our Annual Report on Form 20-F for the year ended December 31, 2025 and our other filings with the SEC, which can be obtained free of charge on the SEC’s website at http://www.sec.gov. Except to the extent required by applicable law, we disclaim any intention or obligation to update publicly or revise any forward‐looking statements, whether as a result of new information, future events or otherwise.

CONTACT DETAILS

For further information please contact:

Investor Relations
Robin Energy Ltd.
Email: ir@robinenergy.com

WOODLAND PARK, N.J., Oct. 23, 2026 (GLOBE NEWSWIRE) — Anterix (NASDAQ: ATEX) announced today that it will hold a conference call on Wednesday, November 11, 2026, at 9:00 a.m. ET. Anterix senior management will discuss the Company’s second quarter fiscal 2027 results. A press release regarding the results will be issued after the close of the market on Tuesday, November 10, 2026.

Participants interested in joining the call’s live question and answer session are required to pre-register by clicking here to obtain a dial-in number and unique PIN. It is recommended that you join the call at least 10 minutes before the conference call begins. The call is also being webcast live and will be accessible on the Investor Relations section of Anterix’s website at https://investors.anterix.com/events-presentations. Following the event, a replay of the call will also be available on the Anterix website.

About Anterix Inc.

Anterix is transforming how critical infrastructure stays connected. As the market leader in mission-critical private wireless broadband spectrum for the utility sector, Anterix delivers more secure, private 900 MHz licensed spectrum and advanced intelligent infrastructure solutions that enhance efficiency, strengthen resilience, and accelerate digital transformation. Backed by a growing ecosystem of industry-leading partners, Anterix provides the connectivity foundation that powers a more resourceful and resilient future. Learn more at www.anterix.com.

Shareholder Contact

Natasha Vecchiarelli
VP, Investor Relations & Corporate Communications
Anterix
nvecchiarelli@anterix.com

LOS ANGELES, CA, Oct. 23, 2026 (GLOBE NEWSWIRE) — Dave Inc. (Nasdaq: DAVE) (“Dave” or the “Company”), one of the nation’s leading neobanks, will host a conference call on Wednesday, November 4, 2026, at 4:30 p.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2026.

Dave management will host the conference call, followed by a question-and-answer period.
The conference call details are as follows:

Date: Wednesday, November 4, 2026
Time: 4:30 p.m. Eastern time
Conference Call Registration: link
Webcast: link

The conference call will also be available for replay in the Events section of the Company’s website, along with the transcript, at https://investors.dave.com.

If you have any difficulty registering for or connecting to the conference call, please contact Elevate IR at DAVE@elevate-ir.com.

About Dave
Dave (Nasdaq: DAVE) is a U.S. neobank pioneering innovative credit products for everyday Americans. For more information about the Company, visit: www.dave.com. For investor information and updates, visit: investors.dave.com and follow @davebanking on X.

Investor Relations Contact
Sean Mansouri, CFA or Stefan Norbom
Elevate IR
DAVE@elevate-ir.com

Media Contact
Dan Ury
press@dave.com

DUNKIRK, N.Y., Oct. 23, 2026 (GLOBE NEWSWIRE) — Lake Shore Bancorp, Inc. (“Lake Shore Bancorp”) (NASDAQ: LSBK), the holding company for Lake Shore Bank (the “Bank”), announced today that the Board of Directors declared a cash dividend of $0.09 per share on its outstanding common stock on October 21, 2026. The dividend is expected to be paid on November 11, 2026 to shareholders of record as of November 2, 2026.

About Lake Shore
  
Lake Shore Bancorp is the holding company of Lake Shore Bank, a New York chartered, community-oriented financial institution headquartered in Dunkirk, New York. The Bank has ten full-service branch locations in Western New York, including four in Chautauqua County and six in Erie County. The Bank offers a broad range of retail and commercial lending and deposit services. Lake Shore Bancorp’s common stock is traded on the NASDAQ Global Market as “LSBK”. Additional information about Lake Shore Bancorp is available at www.mylsbank.com.

Safe-Harbor

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, that are based on current expectations, estimates and projections about Lake Shore Bancorp’s and the Bank’s industry, and management’s beliefs and assumptions. Words such as anticipates, expects, intends, plans, believes, estimates and variations of such words and expressions are intended to identify forward-looking statements. Such statements reflect management’s current views of future events and operations. These forward-looking statements are based on information currently available to Lake Shore Bancorp as of the date of this release. It is important to note that these forward-looking statements are not guarantees of future performance and involve and are subject to significant risks, contingencies, and uncertainties, many of which are difficult to predict and are generally beyond our control including, but not limited to, data loss or other security breaches, including a breach of our operational or security systems, policies or procedures, including cyber-attacks on us or on our third party vendors or service providers, economic conditions, the effect of changes in monetary and fiscal policy, inflation, tariffs, unanticipated changes in our liquidity position, climate change, public health issues, geopolitical conflict, increased unemployment, deterioration in the credit quality of the loan portfolio and/or the value of the collateral securing repayment of loans, reduction in the value of investment securities, the cost and ability to attract and retain key employees, regulatory or legal developments, tax policy changes, dividend policy changes, and our ability to implement and execute our business plan and strategy and expand our operations. These factors should be considered in evaluating forward looking statements and undue reliance should not be placed on such statements, as our financial performance could differ materially due to various risks or uncertainties. We do not undertake to publicly update or revise our forward-looking statements if future changes make it clear that any projected results expressed or implied therein will not be realized. 

Source: Lake Shore Bancorp, Inc.
Category: Financial

Investor Relations/Media Contact
Kim C. Liddell
President, CEO, and Director
Lake Shore Bancorp, Inc.
31 East Fourth Street
Dunkirk, New York 14048
(716) 366-4070 ext. 1012

Largest CrimeTracer deal to date will connect investigative intelligence across up to 10 Texas Anti-Gang Centers to help uncover relationships, develop leads and accelerate investigations

ORLANDO, Fla., Oct. 23, 2026 (GLOBE NEWSWIRE) — SoundThinking, Inc. (Nasdaq: SSTI), a leading public safety technology provider, today announced that CrimeTracer is being deployed to support up to 10 law enforcement agencies participating in the Texas Anti-Gang (TAG) Program. The agreement represents the largest deal in CrimeTracer’s history and will expand access to connected investigative intelligence across the TAG network, enabling participating Centers to search law enforcement data across jurisdictional boundaries and uncover relationships that might otherwise remain hidden.

The TAG program physically establishes regional collocated operational centers where local police, sheriffs, DPS and district attorneys work side-by-side with the aim to identify and disrupt organized criminal networks, share intelligence, coordinate investigations and prosecutions, and reduce violent crime associated with gang activity. But the information needed to support those investigations often resides in separate records management systems, arrest databases, jail records and incident reports across different jurisdictions. Investigators can spend hours manually searching these systems to piece together evidence and connections.

CrimeTracer delivers connected investigative intelligence, enabling investigators to search more than 1 billion CJIS-compliant law enforcement records from across the US in seconds. With more than 50 data types, 3,000 data sources and records spanning more than 2,100 agencies, CrimeTracer is designed to help investigators identify known gang affiliations and associations, reveal hidden connections between suspects, vehicles and locations, and support faster case development and prosecutions.

“The Texas Anti-Gang Program (TAG) seeks to strengthen coordination and collaboration among law enforcement agencies across Texas’s major corridors,” said Jose Morales, San Antonio TAG Administrator. “Through the development of strong interagency partnerships, the TAG Centers aim to enhance information sharing, improve operational coordination, and promote a more effective and efficient response to gang-related activity and violent crime. These collaborative efforts are intended to strengthen public safety and make Texas communities safer. Connecting in a statewide approach is essential because gang activity and violent crime often extend beyond the boundaries of a single jurisdiction and law enforcement agencies must work together to share information and pursue investigative leads across jurisdictions to accomplish that mission. Connecting information across participating TAG Centers gives investigators a more complete picture and supports coordinated investigations achieving better results.”

The deployment is expected to help participating TAG Centers reduce time spent searching disparate systems, accelerate gang investigations and strengthen coordination across jurisdictions.

“Criminal activity doesn’t stop at jurisdictional boundaries, but the information investigators need is often fragmented across agencies and systems,” said Ralph Clark, CEO of SoundThinking. “CrimeTracer connects that information, helping investigators uncover relationships and develop leads across jurisdictions in seconds. The Texas Anti-Gang deployment shows what becomes possible when investigative intelligence is connected across agencies and jurisdictions at scale.”

The TAG expansion builds on CrimeTracer’s existing deployments supporting Harris County and the City of Houston. CrimeTracer already included more than 75 million Texas law enforcement records before this expansion. The deployment is funded through a TAG grant from the Texas Office of the Governor and marks a significant expansion of CrimeTracer’s footprint in Texas.

CrimeTracer is part of SoundThinking’s broader SafetySmart platform, which helps public safety agencies connect data and intelligence from detection through investigation and decision-making.

To learn more about CrimeTracer, visit SoundThinking at the International Association of Chiefs of Police (IACP) Annual Conference and Exposition in Orlando, Fla., booth 1109, Oct. 25-27, 2026, or visit www.SoundThinking.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding CrimeTracer’s ability to help uncover relationships, develop leads and accelerate investigations to prevent gang-related activity and violent crime. Words such as “expect,” “anticipate,” “should,” “believe,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “could,” “intend,” or variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the company’s control. The company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the effect of the announcement of the potential acquisition of the company on the company’s business relationships, including with partners, customers and employees; the diversion of the company’s management’s time and attention from ongoing business operations and opportunities; the impact of global macroeconomic conditions on the company’s business; as well as other risk factors included in the company’s most recent annual report on Form 10-K and other SEC filings. These forward-looking statements are made as of the date of this press release and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the company undertakes no duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events or changes in its expectations.

About SoundThinking
SoundThinking, Inc. (Nasdaq: SSTI) is a leading public safety technology company that delivers AI- and data-driven solutions for law enforcement, civic leadership, and security professionals. SoundThinking is trusted by approximately 300 customers and supports approximately 2,100 agencies to drive more efficient, effective, and equitable public safety outcomes. The company’s SafetySmart™ platform includes ShotSpotter®, the leading acoustic gunshot detection system; CrimeTracer™, the leading law enforcement search engine; SafePointe®, an AI-based weapons detection system; PlateRanger™ (powered by Rekor®), a leading ALPR solution; and Field Agent™, an AI layer that transforms public safety data into actionable intelligence. SoundThinking has been designated a Great Place to Work® Company.

Company Contact:
Alan Stewart, CFO
SoundThinking, Inc.
+1 (510) 794-3100
astewart@soundthinking.com

Investor Relations Contact:
Ankit Hira
Solebury Strategic Communications for SoundThinking, Inc.
+1 (203) 546-0444
SSTI@soleburystrat.com

Source: SoundThinking, Inc.

New evidence integrity, outcomes and auditing capabilities build on patented incident-based retention technology to strengthen privacy and accountability

ORLANDO, Fla., Oct. 23, 2026 (GLOBE NEWSWIRE) — SoundThinking, Inc. (Nasdaq: SSTI), a leading public safety technology provider, today announced new evidence integrity, outcomes and auditing capabilities for PlateRanger™, powered by Rekor^®. The enhancements build on PlateRanger’s incident-based data retention technology, offered for the past two years and now backed by a U.S. patent awarded to Rekor in March 2026.

License plate recognition provides significant investigative value, but agencies and communities increasingly expect stronger safeguards governing what vehicle data is retained, how long it is kept and how it is used. PlateRanger is built on a simple premise: not every plate read needs to be treated the same.

PlateRanger allows agencies to establish retention periods based on the investigative relevance of vehicle data. For example, routine plate reads could be automatically deleted after just two days, while records associated with stolen vehicles, AMBER Alerts or other qualifying investigative activity could be retained for 90 days or longer, according to agency-defined policies. Rekor’s patented technology enables this differentiated retention based on the severity of suspected criminal activity.

By limiting unnecessary retention of data about everyday drivers while preserving valuable investigative information, we believe PlateRanger helps agencies balance public safety with privacy and community trust. Importantly, PlateRanger data is always owned by the agency—not the technology provider. Each agency controls its data-sharing policies, including which partners can access information and whether to participate in broader sharing networks.

“In Bellflower, we expect our public safety technology to be both effective and responsible,” said Brian McNerney, Director of Public Safety for the City of Bellflower, CA. “PlateRanger has helped our law enforcement partner, the Los Angeles County Sheriff’s Department, identify vehicles involved in street racing and street takeovers, which put lives at risk in our neighborhoods. But protecting our community also means respecting the privacy of people going about their daily lives, and the system lets the Sheriff’s Department do both. That’s how we earn and keep our residents’ trust.”

As generative AI and synthetic media raise new questions about digital evidence, law enforcement agencies increasingly need ways to verify that video footage is authentic. GoSecure, an upcoming capability for PlateRanger Edge Max cameras and cameras powered by Axis Agent, will cryptographically authenticate video at the point of capture, helping investigators and prosecutors establish confidence in its integrity.

PlateRanger Outcomes, now available, connects LPR alerts to measurable results, including arrests, recovered vehicles and cases assisted. An agency-wide dashboard helps supervisors assess the system’s contribution to investigations and public safety, providing greater visibility into the value of their LPR deployments.

Enhanced auditing capabilities give agencies greater visibility into how PlateRanger is used, including administrative and configuration activity. These enhancements build on existing safeguards such as role-based access, search justification and audit trails, helping agencies monitor system use and demonstrate adherence to their policies.

“The debate around license plate recognition is too often framed as public safety versus privacy. It doesn’t have to be,” said Ralph Clark, President and CEO of SoundThinking. “Routine vehicle data with no investigative relevance shouldn’t be retained unnecessarily, while information tied to legitimate public safety needs should remain available to investigators. We believe responsible LPR means more than protecting data. It also means ensuring evidence integrity, demonstrating measurable outcomes and giving agencies transparency and control over how the technology is used.”

Attendees at the International Association of Chiefs of Police (IACP) Annual Conference and Exposition in Orlando, Fla., can learn more about PlateRanger at Booth 1109 during the exposition, Oct. 25–27, 2026. Agencies can also request a demonstration at SoundThinking.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the potential ability of PlateRanger to balance public safety with privacy and community trust. Words such as “expect,” “anticipate,” “should,” “believe,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “could,” “intend,” or variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the company’s control. The company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the effect of the announcement of the potential acquisition of the company on the company’s business relationships, including with partners, customers and employees; the diversion of the company’s management’s time and attention from ongoing business operations and opportunities; the impact of global macroeconomic conditions on the company’s business; as well as other risk factors included in the company’s most recent annual report on Form 10-K and other SEC filings. These forward-looking statements are made as of the date of this press release and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the company undertakes no duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events or changes in its expectations.

About SoundThinking
SoundThinking, Inc. (Nasdaq: SSTI) is a leading public safety technology company that delivers AI- and data-driven solutions for law enforcement, civic leadership, and security professionals. SoundThinking is trusted by approximately 300 customers and supports approximately 2,100 agencies to drive more efficient, effective, and equitable public safety outcomes. The company’s SafetySmart™ platform includes ShotSpotter^®, the leading acoustic gunshot detection system; CrimeTracer™, the leading law enforcement search engine; SafePointe^®, an AI-based weapons detection system; PlateRanger™ (powered by Rekor^®), a leading ALPR solution; and Field Agent™, an AI layer that transforms public safety data into actionable intelligence. SoundThinking has been designated a Great Place to Work^® Company.

Company Contact:
Alan Stewart, CFO
SoundThinking, Inc.
+1 (510) 794-3100
astewart@soundthinking.com

Investor Relations Contact:
Ankit Hira
Solebury Strategic Communications for SoundThinking, Inc.
+1 (203) 546-0444
SSTI@soleburystrat.com

Source: SoundThinking, Inc.

KOBE, Japan, Oct. 23, 2026 (GLOBE NEWSWIRE) — Micware Co., Ltd. (Nasdaq: MWC) (the “Company” or “Micware”), a Japan-based provider of in-vehicle infotainment, navigation, and location-based software for automakers including Honda and Toyota, today announced that it will release its financial results for the six months ended August 31, 2026, on Tuesday, November 10, 2026, U.S. Eastern Time.

The Company will host an English-language earnings call on Tuesday, November 10, 2026, at 5:00 p.m. U.S. Eastern Time (Wednesday, November 11, 2026, at 7:00 a.m. Japan Standard Time), followed by a Japanese-language earnings call on Wednesday, November 11, 2026, at 2:00 a.m. U.S. Eastern Time (4:00 p.m. Japan Standard Time).

To attend these earnings calls, please use the information below for access.

English-language Earnings Call
Date:	November 10, 2026
Time:	5:00 p.m. U.S. Eastern Time (Wednesday, November 11, 2026, at 7:00 a.m. Japan Standard Time)
Pre-registration Link:	https://us06web.zoom.us/webinar/register/WN_RXbMwE5YRk-HATpIcrPoIw

Japanese-language Earnings Call
Date:	November 11, 2026
Time:	2:00 a.m. U.S. Eastern Time (4:00 p.m. Japan Standard Time)
Pre-registration Link:	https://us06web.zoom.us/webinar/register/WN_W_tnqRaERt-RLm88l27l6Q

For participation in the earnings calls, pre-registration is required using the links above. Dial-in details and access instructions will be provided upon registration. Please join at least 15 minutes before the commencement of the calls to ensure timely participation.

For those unable to participate, video replays will be available approximately one hour after the end of each live call. The replay of the English-language earnings call will be available until November 10, 2027 U.S. Eastern Time, while the replay of the Japanese-language earnings call will be available until November 11, 2027 U.S. Eastern Time.

An archived webcast of the earnings calls will also be available at the Company’s investor relations website at www.ir-micware.com.

About Micware Co., Ltd.

Micware Co., Ltd. (Nasdaq: MWC) is a Japan-based provider of in-vehicle infotainment, navigation, and location-based software for automakers including Honda and Toyota. These capabilities also form the foundation of its spatial intelligence business.

Headquartered in Kobe and led by Founder and CEO Mr. Kenji Narushima since 2003, Micware operates 13 offices across Japan, the United States, Thailand, and Germany.

Through a platform-based growth strategy, Micware aims to extend its software into advanced driver assistance and connected services with micAuto-PF, and to link real-world and virtual 3D spaces with DynaPlanet-PF.

For more information, visit Micware’s IR website at www.ir-micware.com and its LinkedIn page at www.linkedin.com/company/micware-company-limited.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may,” or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. These statements are subject to uncertainties and risks, including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the “Risk Factors” section of the annual report on Form 20-F filed with the U.S. Securities and Exchange Commission (the “SEC”). Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the annual report on Form 20-F and other filings with the SEC. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov.

For more information, please contact:

Micware Co., Ltd.
Investor Relations Department
Email: mic_ir@micware.co.jp

Public Relations
Email: mic_pr@micware.co.jp

Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com